MIC current news
The updated ‘National Malaria Treatment Guidelines 2017’ (final draft version) can be accessed on the NICD website (www.nicd.ac.za).
Ning and colleagues recently published their research in the Journal of Psychopharmacology. Their study looked at reducing the dose of olanzapine or risperidone in stable schizophrenic patients and the effect on cognitive function and symptoms.
The newest edition of the SAMF – the 13th – has been published. This is an extremely valuable resource for all healthcare workers.
Biogen presented trial data last year, November, at the Clinical Trials on Alzheimer’s Disease conference in San Diego, for their drug aducanumab.
Nocerino and colleagues, from the University of Naples in Italy, published the results of their study which looked at the efficacy of a particular strain (Bifidobacterium animalis subsp. lactis BB-12) of probiotic for the management of infant colic.
It’s an exciting time to be in the field of HIV as the Minister of Health, Dr Zweli Mkhize, announced the launch of the new guidelines.
Interesting results from a chronotherapy study on BP medication were published in the European Heart Journal recently, showing that it may be better to take antihypertensives at bedtime.
A medicine safety letter highlights the risk of acute kidney injury in patients treated with fluoroquinolones concomitantly with ace-inhibitors (ACEIs) or angiotensin receptor blockers (ARBs).
An article in the February Lancet discussed lessons learnt from eleven countries that are moving toward universal health coverage (UHC). An interesting read, as South Africa negotiates a National Health Insurance system.
Prescription drugs were previously assigned pregnancy categories A, B, C, D and X, which essentially over-simplified the issue. These categories will now be replaced with three detailed sub-sections that describe risks in a real world context.
In March 2013 the UK Medicines and Healthcare Products Regulatory Agency conducted a review of published literature on the benefits and risks of aqueous cream, especially when used for children with eczema. Both the NICE paediatric guidelines and the British National Eczema Society report that aqueous cream as a leave-on emollient (but not when used as a soap substitute) may cause stinging, itching, burning or redness. This was based on an audit of 100 children attending a dermatology clinic conducted by Cork MJ et al.